DDO-2093

CAT: 0804-HY-132233Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-132233Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
DDO-2093 is a potent MLL1-WDR5 protein-protein interaction inhibitor (IC50=8.6 nM; Kd=11.6 nM) with antitumor activity. DDO-2093 selectively inhibits the catalytic activity of MLL complex[1].
CAS Number
[2250024-74-7]
UNSPSC
12352005
Target
WDR5
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ddo-2093.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=CN(C2=CC=C(N3CCN(C)CC3)C(NC(C4=CC(N)=C(F)C(C)=C4Cl)=O)=C2)N=N1)NCCCN5CCOCC5
Molecular Formula
C29H37ClFN9O3
Molecular Weight
614.11
References & Citations
[1]Chen W, et al. Discovery of a potent MLL1 and WDR5 protein-protein interaction inhibitor with in vivo antitumor activity [published online ahead of print, 2021 Jun 28]. Eur J Med Chem. 2021;223:113677.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-103340O-2093
HY-149863DDO-8926
HY-153331-01DDO-2213
HY-144801ADDO-02005
HY-144634-01DDO-7263
HY-139301-01DDO-5936
HY-155489-01DDO-2728
HY-170668DDO-02267
HY-169947-01DDO-6079
HY-147125DDO-6600

Alternative Products

CatalogName
T39769DDO-2093
MBS5814693DDO-2093 dihydrochloride
MBS5757571O-2093
CSB-CL006593HUDDO
588344DDO (DASOX, DDO-1, DDO-2, FLJ45203, aspartic oxidase)
245248DDO (D-Aspartate Oxidase, DASOX, DDO-1, DDO-2, FLJ45203)
034538DDO, ID (DDO, D-aspartate oxidase)
MBS3613714-01DDO-5936
560153-01DDO (FITC)
MBS7048013-01DDO Antibody

Popular Products